Matinas BioPharma Holdings MTNB
NYSE MTNB
$1.59 -0.11 (-6.48%)
As of: Oct 21, 2026 · 3:59 PM EDT

Matinas BioPharma Holdings (MTNB) Debt Ratio (2015 - 2019)

Updated

Matinas BioPharma Holdings' (MTNB) Debt Ratio was 0.00 for Q1 2019, down 57.3% from 0.00 a year earlier and down 84.2% from the prior quarter.

Analysis

Matinas BioPharma Holdings (MTNB) Debt Ratio (2015 - 2019) Analysis & Trends

For FY2018, Debt Ratio at Matinas BioPharma Holdings was 0.01, down 15.1% from FY2017.

  • By year, Debt Ratio came in at 0.01 in FY2017 (-1.9%) and 0.01 in FY2016.
  • The Q1 2019 figure ranks as the lowest quarterly Debt Ratio since Q3 2015.
  • Year over year, Debt Ratio gained in three of the last six quarters, with growth averaging 4.9%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.39
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.24
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.52
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.42
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.08
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.28
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.60
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.53
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 Matinas BioPharma Holdings 679,055.62 -11.91 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 0.00
Dec 31, 2018 0.01
Sep 30, 2018 0.02
Mar 31, 2018 0.00
Dec 31, 2017 0.01
Sep 30, 2017 0.02
Mar 31, 2017 0.00
Dec 31, 2016 0.01
Sep 30, 2016 0.02
Sep 30, 2015 0.00
Jun 30, 2015 0.00
Mar 31, 2015 0.00
API Access

Matinas BioPharma Holdings Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=MTNB&period=max&api_key=YOUR_API_KEY